|
|||||
|
|
COVID-19 update: Covid-19-associated coagulopathy |
|
| Authors: | Becker Richard C. |
| Affiliation: | 1.Division of Cardiology, Loyola University Chicago, Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ;2.Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA ;3.Division of Cardiovascular Disease, Department of Medicine, University of Michigan, Ann Arbor, MI, USA ;4.Division of Pharmacology, Loyola University Chicago Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ;5.Division of Vascular Surgery, Loyola University Chicago Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ;6.Department of Medicine, Loyola University Chicago Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ;7.Department of Pathology, Loyola University Chicago Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ;8.Division of Cardiology, Cardiovascular Research Institute, Loyola University Chicago, Stritch School of Medicine, 2160 South First Ave, Maywood, IL, USA ; |
| Abstract: | Journal of Thrombosis and Thrombolysis - A subset of high-risk pulmonary embolism (PE) patients requires advanced therapy beyond anticoagulation. Significant variation in delivery of care has led... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |